← Back to Search

Procedure

Adolescent Overweight for Type 1 Diabetes (T1D Trial)

N/A
Waitlist Available
Led By Michelle Van Name, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 240 minutes
Awards & highlights

T1D Trial Summary

This trial will look at how extra weight (adiposity) affects insulin's ability to control blood sugar in obese adolescents with type 1 diabetes. It will also examine how fatty liver disease affects insulin resistance in these teens.

Eligible Conditions
  • Type 1 Diabetes
  • Obesity

T1D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~240 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 240 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hepatic Sensitivity to Low Dose Insulin
Peripheral Sensitivity to High Dose Insulin
Rate of Glucose Metabolism
+1 more

T1D Trial Design

3Treatment groups
Experimental Treatment
Group I: Young AdultExperimental Treatment1 Intervention
Young adults with T1D with a euglycemic hyperinsulinemic clamp with tracer enhancement
Group II: Adolescent TypicalExperimental Treatment1 Intervention
Lean adolescents with T1D
Group III: Adolescent OverweightExperimental Treatment1 Intervention
Adolescents with T1D and overweight/obesity

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,863 Previous Clinical Trials
2,742,558 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,377 Previous Clinical Trials
4,315,788 Total Patients Enrolled
Michelle Van Name, MDPrincipal InvestigatorYale University
2 Previous Clinical Trials
69 Total Patients Enrolled
~4 spots leftby Jun 2025